[HTML][HTML] Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies

A Mukherjee, KM Pandey, KK Ojha… - Beni-Suef University …, 2023 - Springer
Background COVID-19 was declared a pandemic by the World Health Organisation in 2020
after its outbreak in December 2019 in Wuhan, China. Since researchers have been working …

[HTML][HTML] In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease

I Khater, A Nassar - Biochemistry and Biophysics Reports, 2021 - Elsevier
Developing a safe and effective antiviral treatment takes a decade, however, when it comes
to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the …

In silico Study to Identification of Potential SARS-CoV-2 Main Protease Inhibitors: Virtual Drug Screening and Molecular Docking with AutoDock Vina and Molegro …

MA Manavi - Journal of Cell and Molecular Research, 2022 - jcmr.um.ac.ir
Coronavirus disease 2019 (COVID-19) has emerged in Wuhan, China, and because of fast
transmission, it has led to its extensive prevalence in almost all countries, which has made it …

A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor

S Mathpal, T Joshi, P Sharma, T Joshi… - Journal of …, 2022 - Taylor & Francis
The sudden outbreak of COVID-19 has been responsible for several deaths across the
globe. Due to its high contagious nature, it spreads from one human to another very quickly …

[HTML][HTML] Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations

DS Jairajpuri, A Hussain, K Nasreen… - Saudi Journal of …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has emerged from China and globally
affected the entire population through the human-to-human transmission of a newly …

In silico identification of clinically approved medicines against the main protease of SARS-CoV-2, causative agent of covid-19

E Mamidala, R Davella, S Gurrapu… - arXiv preprint arXiv …, 2020 - arxiv.org
The COVID-19 pandemic triggered by SARS-CoV-2 is a worldwide health disaster. Main
protease is an attractive drug target among coronaviruses, due to its vital role in processing …

[HTML][HTML] In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)

E Aghaee, M Ghodrati, JB Ghasemi - Informatics in Medicine Unlocked, 2021 - Elsevier
The spread of SARS-CoV-2 has affected human health globally. Hence, it is necessary to
rapidly find the drug-candidates that can be used to treat the infection. Since the main …

Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation …

FS Hosseini, M Amanlou - Life sciences, 2020 - Elsevier
Abstract Aims Coronavirus disease 2019 (COVID-19) has appeared in Wuhan, China but
the fast transmission has led to its widespread prevalence in various countries, which has …

An in-silico evaluation of COVID-19 main protease with clinically approved drugs

W Tachoua, M Kabrine, M Mushtaq, Z Ul-Haq - Journal of molecular …, 2020 - Elsevier
A novel strain of coronavirus, namely, SARS-CoV-2 identified in Wuhan city of China in
December 2019, continues to spread at a rapid rate worldwide. There are no specific …

[HTML][HTML] ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19

Z Fakhar, S Khan, SY AlOmar, A Alkhuriji, A Ahmad - Scientific Reports, 2021 - nature.com
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …